Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA

EU orphan designation number: EU/3/11/857   
Active ingredient: Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA
Indication: Treatment of familial amyloid polyneuropathy
Sponsor: Voisin Consulting S.A.R.L.
3 rue des Longs Prés, F-92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/04/2011 Centralised Orphan - Designation EMA/OD/142/10 (2011)2844 of 15/04/2011